Bipolar Bozukluk ve Romatoid Artrit İlişkisi

Melike Mandacı, (Bursa Uludağ Üniversitesi, Bursa, Türkiye)
Aslı Sarandöl, (Bursa Uludağ Üniversitesi, Bursa, Türkiye)
Cengiz Akkaya (Bursa Uludağ Üniversitesi, Bursa, Türkiye)
Psikiyatride Güncel Yaklaşımlar
18 1
Yıl: 2022 Cilt: 14 Sayı: 2 Sayfa Aralığı: 131 - 142 Metin Dili: Türkçe DOI: 10.18863/pgy.921569 İndeks Tarihi: 29-07-2022

Bipolar Bozukluk ve Romatoid Artrit İlişkisi

Öz:
Romatoid artrit, sinovit, sistemik inflamasyon, artrit ve vaskülit, anemi, mononörit, pulmoner fibrozis gibi eklem dışı sistem tutulumu ile karakterize olan zamanında ve yeterli tedavi edilmezse eklem destruksiyonuna, eklem hareketlerinin kısıtlanmasına, hastanın yaşam kalitesinin bozulmasına neden olabilecek kronik bir otoimmün hastalıktır. Romatoid artrit hastalarında eklem bulgularının yanı sıra klinik tabloya bilişsel işlev bozukluğu, davranış değişiklikleri ve duygudurum değişiklikleri gibi nöropsikiyatrik belirtiler de eşlik edebilir. Romatoid artrit hastalarında nöroinflamatuar sürecin, plazmadaki proinflamatuar sitokin düzeylerinde artışın, uzun süre kullanılan ilaçların yan etkilerinin, hastalıkla birlikte oluşan yeti yitiminin ve olası ortak gen bölgelerinin bu belirtilere neden olabileceği düşünülmektedir. Romatoid artrit hastalarında psikiyatrik semptom ve bozukluklarla ilgili giderek artan sayıda çalışmalar yayınlanmaktadır. Özellikle anksiyete bozuklukları ve major depresif bozukluk ile ilişkisine odaklanan birçok çalışma mevcuttur. Bipolar bozukluk etiyolojisinde immün fonksiyonlarda bozulmanın yer aldığına ilişkin giderek artan sayıda çalışma bulunmaktadır. Bipolar bozukluk hastalarının plazmalarında sitokin düzeylerinde değişiklikler görülmesi bu görüşü destekler niteliktedir. Çeşitli otoimmün hastalıklarla bipolar bozukluk arasındaki ilişki baraştırılmaya devam edilmektedir. Romatolojik hastalığı olan bireylerde, psikiyatrik eş tanılar açısından dikkatli olunması hastaların tedaviye uyumu ve klinik seyir açısından önemlidir.
Anahtar Kelime: psikonöroimmünoloji bipolar bozukluk romatoid artrit inflamasyon

Relationship between Bipolar Disorder and Rheumatoid Arthritis

Öz:
Rheumatoid arthritis is a chronic autoimmune disease that is characterized by synovitis, systemic inflammation, arthritis and vasculitis, anemia, mononeuritis, pulmonary fibrosis, and can cause joint destruction, limitation of joint movements and impairment of the patient's quality of life if not treated in right time and adequate manner. In addition to joint symptoms, neuropsychiatric symptoms such as cognitive dysfunction, behavioral changes, and mood changes may accompany rheumatoid arthritis patients. It is thought that neuroinflammatory process in rheumatoid arthritis patients, increase in proinflammatory cytokine levels in plasma; side effects of drugs used for a long time, disability that occurs with the disease, and possible common gene regions may cause these symptoms. An increasing number of studies are being published on psychiatric symptoms and disorders in patients with rheumatoid arthritis. There are many studies focusing especially on its relationship with anxiety disorders and major depressive disorder. There are increasing numbers of studies showing that the impairment of immune functions is involved in the etiology of bipolar disorder. The changes in cytokine levels in the plasma of bipolar disorder patients supports this argument. The relationship between various autoimmune diseases and bipolar disorder continues to be examined. In people with rheumatological diseases, it is important to be careful in psychiatric comorbidities in terms of patient compliance and clinical course.
Anahtar Kelime: bipolar disorder

Belge Türü: Makale Makale Türü: Derleme Erişim Türü: Erişime Açık
  • Abbott NJ, Ronnback L, Hansson E (2006) Astrocyte-endothelial interactions at the blood-brain barrier. Nat Rev Neurosci, 7:41–53.
  • Arias I, Sorlozano A, Villegas E, de Dios Luna J, McKenney K, Cervilla J et al. (2012) Infectious agents associated with schizophrenia: a meta-analysis. Schizophr Res, 136:128-136.
  • Austin M, Tan YCJ (2012) Mania associated with infliximab. Aust N Z J Psychiatry, 46:684–685.
  • Banerjee S, Biehl A, Gadina M, Hasni S, Schwartz DM (2017) JAK-STAT signaling as a target for inflammatory and autoimmune diseases: current and future prospects. Drugs, 5:521–546.
  • Belt N, Kronholm E, Kauppi M (2009) Sleep problems in fibromyalgia and rheumatoid arthritis compared with the general population. Clin Exp Rheumatol, 27:35-41.
  • Belvederi Murri M, Prestia D, Mondelli V, Pariante C, Patti S, Olivieri B et al. (2016) The HPA axis in bipolar disorder: systematic review and metaanalysis. Psychoneuroendocrinology, 63:327–342.
  • Benedetti F, Aggio V, Pratesi ML, Greco G, FurlanR (2020) Neuroinflammation in bipolar depression. Front Psychiatry, 11:71.
  • Benros ME, Waltoft BL, Nordentoft M, Ostergaard SD, Eaton WW, Krogh J, et al. (2013) Autoimmune diseases and severe infections as risk factors for mood disorders: a nationwide study. JAMA Psychiatry, 70:812-820.
  • Berk M, Kapczinski F, Andreazza AC, Dean OM, Giorlando F, Maes M et al. (2011) Pathways underlying neuroprogression in bipolar disorder: focus on inflammation, oxidative stress and neurotrophic factors. Neurosci Biobehav Rev, 35:804–817.
  • Berk M, Williams L, Jacka F, O’Neil A, Pasco J, Moylan S et al. (2013) So depression is an inflammatory disease, but where does the inflammation come from? BMC Med, 11:200.
  • Blackburn-Munro G, Blackburn-Munro RE (2001) Chronic pain, chronic stress and depression: coincidence or consequence? J Neuroendocrinol, 13:1009–1023.
  • Bogaczewicz J, Sobów T, Bogaczewicz A, Robak E, Bienkowski P, SysaJedrzejowska A et al. (2014) Exacerbations of bipolar disorder triggered by chloroquine in systemic lupus erythematosus-a case report. Lupus, 23:188-193.
  • Bolanos SH, Khan DA, Hanczyc M, Bauer MS, Dhanani N, Brown ES (2004) Assessment of mood states in patients receiving long-term corticosteroid therapy and in controls with patient-rated and clinician-rated scales. Ann Allergy Asthma Immunol, 92:500-505.
  • Brierley MM, Fish EN (2005) Stats: multifaceted regulators of transcription. J Interferon Cytokine Res, 25:733-744.
  • Brietzke E, Kapczinski F (2008) TNF-α as a molecular target in bipolar disorder. Prog Neuropsychopharmacol Biol Psychiatry, 32:1355–1361. Brietzke E, Stertz L, Fernandes BS, Kauer-Sant’anna M, Mascarenhas
  • M, Escosteguy Vargas A et al. (2009) Comparison of cytokine levels in depressed, manic and euthymic patients with bipolar disorder. J Affect Disord, 116:214-217.
  • Brietzke E, Lafer B (2010) Induction of manic switch by the tumor necrosis factor-α antagonist infliximab. Psychiatry Clin Neurosci, 64:442–443.
  • Bruce TO (2008) Comorbid depression in rheumatoid arthritis: pathophysiology and clinical implications. Curr Psychiatry Rep, 10:258-264.
  • Carpenter LL, Gawuga CE, Tyrka AR, Lee JK, Anderson GM, Price LH (2010) Association between plasma IL-6 response to acute stress and early-life adversity in healthy adults. Neuropsychopharmacology, 35:2617-2623.
  • Ceïde ME, Rosenberg PB (2011) Brief Manic episode after Rituximab Treatment of limbic encephalitis. J Neuropsychiatry Clin Neurosci, 23(4):E8.
  • Chebli S, Zgueb Y, Ouali U, Taleb S, Nacef F (2020) Bipolar disorder as comorbidity with Sjogren’s syndrome: what can we do? Case Rep Psychiatry, 2020:8899615.
  • Chen M, Zhang L, Jiang Q (2020) Peripheral IGF-1 in bipolar disorder and major depressive disorder: a systematic review and meta-analysis. Ann Palliat Med, 9:4044-4053.
  • Cohen S, Janicki-Deverts D, Doyle WJ, Miller GE, Frank E, Rabin BS et al. (2012) Chronic stress, glucocorticoid receptor resistance, inflammation, and disease risk. Proc Natl Acad Sci U S A, 109:5995-5999.
  • Cole DP, Thase ME, Mallinger AG, Soares JC, Luther JF, Kupfer DJ, Frank E (2002) Slower treatment response in bipolar depression predicted by lower pretreatment thyroid function. Am J Psychiatry, 159:116-121.
  • Corfield EC, Martin NG, Nyholt DR (2016) Co-occurrence and symptomatology of fatigue and depression. Compr Psychiatry, 71:1-10.
  • Covic T, Cumming SR, Pallant JF, Manolios N, Emery P, Conaghan PG et al. (2012) Depression and anxiety in patients with rheumatoid arthritis: prevalence rates based on a comparison of the Depression, Anxiety and Stress Scale (DASS) and the hospital, Anxiety and Depression Scale (HADS). BMC Psychiatry, 12:6.
  • Cremaschi L, Kardell M, Johansson V et al. (2017) Prevalences of autoimmune diseases in schizophrenia, bipolar I and II disorder, and controls. Psychiatry Res, 258:9-14.
  • Cross M, Smith E, Hoy D, Carmona L, Wolfe F, Vos T et al. (2014) The global burden of rheumatoid arthritis: estimates from the global burden of disease 2010 study. Ann Rheum Dis, 73:1316-1322.
  • Cutolo M, Kitas GD, van Riel PL (2014) Burden of disease in treated rheumatoid arthritis patients: going beyond the joint. Semin Arthritis Rheum, 43:479-488.
  • Daban C, Vieta E, Mackin P, Young AH (2005) Hypothalamic-pituitaryadrenal axis and bipolar disorder. Psychiatr Clin North Am, 28:469-480.
  • Danese AJ, Lewis S (2017) Psychoneuroimmunology of early-life stress: the hidden wounds of childhood trauma? Neuropsychopharmacology, 42:99-114.
  • Deisseroth A, Kaminskas E, Grillo J, Chen W, Saber H, Lu HL et al. (2012) U.S. Food and Drug Administration approval: ruxolitinib for the treatment of patients with intermediate and high-risk myelofibrosis. Clin Cancer Res, 12:3212–3217.
  • Dickens C, McGowan L, Clark-Carter D, Creed F (2002) Depression in rheumatoid arthritis: a systematic review of the literature with metaanalysis. Psychosom Med, 64:52–60.
  • Dickerson F, Origoni A, Schroeder J, Schweinfurth LA, Stallings C, Savage CL et al. (2016) Mortality in schizophrenia and bipolar disorder: Clinical and serological predictors. Schizophr Res, 170:177-183.
  • Drago A, Crisafulli C, Calabro M, Serretti A (2015) Enrichment pathway analysis. The inflammatory genetic background in Bipolar Disorder. J Affect Disord, 179:88-94.
  • Drexhage RC, Hoogenboezem TH, Versnel MA, Berghout A, Nolen WA, Drexhage HA (2011) The activation of monocyte and T cell networks in patients with bipolar disorder. Brain Behav Immun, 25:1206-1213.
  • Dube SR, Fairweather D, Pearson WS, Felitti VJ, Anda RF, Croft JB (2009) Cumulative childhood stress and autoimmune diseases in adults. Psychosom Med, 71:243-250.
  • Eaton WW, Byrne M, Ewald H, Mors O, Chen CY, Agerbo E et al. (2006) Association of schizophrenia and autoimmune diseases: linkage of Danish national registers. Am J Psychiatry, 163:521-528.
  • Eaton WW, Pedersen MG, Nielsen PR, Mortensen PB (2010) Autoimmune diseases, bipolar disorder, and non-affective psychosis. Bipolar Disord, 12:638–646.
  • Edwards RR, Cahalan C, Mensing G, Smith M, Haythornthwaite JA (2011) Pain, catastrophizing, and depression in the rheumatic diseases. Nat Rev Rheumatol, 7:216–224.
  • Englbrecht M, Gossec L, DeLongis A, Scholte-Voshaar M, Sokka T, Kvien TK et al. (2012) The impact of coping strategies on mental and physical well-being in patients with rheumatoid arthritis. Semin Arthritis Rheum, 41:545-555.
  • Evers AW, Zautra A, Thieme K. (2011) Stress and resilience in rheumatic diseases: a review and glimpse into the future. Nat Rev Rheumatol. 7:409–415.
  • Fifield J, McQuillan J, Tennen H, Sheehan TJ, Reisine S, Hesselbrock V et al. (2001) History of affective disorder and the temporal trajectory of fatigue in rheumatoid arthritis. Ann Behav Med, 23:34-41.
  • Firestein GS, McInnes IB (2017) Immunopathogenesis of rheumatoid arthritis. Immunity, 46:183–96.
  • Forty L, Ulanova A, Jones L et al. (2014) Comorbid medical illness in bipolar disorder. Br J Psychiatry, 205:465-472.
  • Fragiadaki K, Tektonidou MG, Konsta M, Chrousos GP, Sfikakis PP (2012) Sleep disturbances and interleukin 6 receptor inhibition in rheumatoid arthritis. J Rheumatol, 39:60–62.
  • Goldsmith DR, Rapaport MH, Miller BJ (2016) A meta-analysis of blood cytokine network alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder and depression. Mol Psychiatry, 21:1696-1709.
  • Hauser W, Bernardy K, Uceyler N, Sommer C (2009) Treatment of fibromyalgia syndrome with antidepressants: a metaanalysis. JAMA, 301:198–209.
  • Ho RC, Fu EH, Chua AN, Cheak AA, Mak A (2011) Clinical and psychosocial factors associated with depression and anxiety in Singaporean patients with rheumatoid arthritis. Int J Rheum Dis, 14:37-47.
  • Hou L, Bergen SE, Akula N, Song J, Hultman CM, Landén M et al. (2016) Genome-wide association study of 40,000 individuals identifies two novel loci associated with bipolar disorder. Hum Mol Genet, 25:3383-3394.
  • Hsu WH, Chiu NY, Huang SS. (2011) Hydroxychloroquine-induced acute psychosis in a systemic lupus erythematosus female. Acta Neuropsychiatr, 23:318–319.
  • Imeri L, Opp MR (2009) How (and why) the immune system makes us sleep. Nat Rev Neurosci, 10:199–210.
  • Imran MY, Khan SEA, Ahmad NM, Raja SF, Saeed MA, Haider II (2015) Depression in rheumatoid arthritis and its relation to disease activity. Pak J Med Sci, 31:393–397.
  • Irwin M, Rinetti G, Redwine L, Motivala S, Dang J, Ehlers C (2004) Nocturnal proinflammatory cytokine-associated sleep disturbances in abstinent African American alcoholics. Brain Behav Immun, 18:349–360.
  • Isgren A, Jakobsson J, Pålsson E, Ekman CJ, Johansson AG, Sellgren C et al. (2015) Increased cerebrospinal fluid interleukin-8 in bipolar disorder patients associated with lithium and antipsychotic treatment. Brain Behav Immun, 43:198-204.
  • Isik A, Koca SS, Ozturk A, Mermi O (2007) Anxiety and depression in patients with rheumatoid arthritis. Clin. Rheumatol, 26:872-8.
  • Ivković M, Pantović-Stefanović M, Dunjić-Kostić B, Jurišić V, Lačković M, Totić-Poznanović S et al. (2016) Neutrophilto-lymphocyte ratio predicting suicide risk in euthymic patients with bipolar disorder: Moderatory effect of family history. Compr Psychiatry, 66:87-95.
  • Jakobsson J, Bjerke M, Sahebi S, Isgren A, Ekman CJ, Sellgren C et al. (2015) Monocyte and microglial activation in patients with mood-stabilized bipolar disorder. J Psychiatry Neurosci, 40:250-258.
  • Joharatnam N, McWilliams DF, Wilson D, Wheeler M, Pande I, Walsh DA (2015) A cross-sectional study of pain sensitivity, disease-activity assessment, mental health, and fibromyalgia status in rheumatoid arthritis. Arthritis Res Ther, 17:11.
  • Julius D, Basbaum AI (2001) Molecular mechanisms of nociception. Nature, 413:203-210.
  • Kanju PM, Parameshwaran K, Vaithianathan T (2007) Lysosomal dysfunction produces distinct alterations in synaptic alpha-amino-3- hydroxy-5-methylisoxazolepropionic acid and N-methyl-D-aspartate receptor currents in hippocampus. J Neuropathol Exp Neurol, 66:779-788.
  • Kaufman KR (2005) Etanercept, anticytokines and mania. Int Clin Psychopharmacol, 20:239–241.
  • Kekow J, Moots R, Khandker R, Melin J, Freundlich B, Singh A (2011) Improvements in patient-reported outcomes, symptoms of depression and anxiety, and their association with clinical remission among patients with moderate-to-severe active early rheumatoid arthritis. Rheumatology (Oxford), 50:401-409.
  • Kelley WN, Harris ED Jr, Ruddy S, Sledge CB (2001) Textbook of Rheumatology, 6th ed.. Philadelphia, Saunders Company.
  • Klengel T, Mehta D, Anacker C, Rex-Haffner M, Pruessner JC, Pariante CM et al. (2013) Allele-specific FKBP5 DNA demethylation mediates genechildhood trauma interactions. Nat Neurosci, 16:33-41.
  • Kojima M, Kojima T, Suzuki S, Oguchi T, Oba M, Tsuchiya H et al. (2009) Depression, inflammation, and pain in patients with rheumatoid arthritis. Arthritis Rheum, 61:1018–1024.
  • Kubera M, Lin AH, Kenis G, Bosmans E, Van Bockstaele D, Maes M (2001) Anti-inflammatory effects of antidepressants through suppression of the interferon-gamma/interleukin10 production ratio. J Clin Psychopharmacol, 21:199–206.
  • Kuipers RK (1962) Imipramine in the treatment of rheumatic patients. Acta Rheumatol Scand, 8:45–51.
  • Kuwabara T, Matsui Y, Ishikawa F, Kondo M (2018) Regulation of T-cell signaling by post-translational modifications in autoimmune disease. Int J Mol Sci, 19:819.
  • Labonte B, Suderman M, Maussion G, Navaro L, Yerko V, Mahar I et al. (2012) Genome-wide epigenetic regulation by early-life trauma. Arch Gen Psychiatry, 69:722-731.
  • Lampa J, Westman M, Kadetoff D, Agréus AN, Le Maître E, GillisHaegerstrand C et al. (2012) Peripheral inflammatory disease associated with centrally activated IL-1 system in humans and mice. Proc Natl Acad Sci U S A, 109:12728–12733.
  • Li C, Yang C, Gelernter J, Zhao HY (2014) Improving genetic risk prediction by leveraging pleiotropy. Hum Genet, 133:639–650.
  • Luo Y, He H, Zhang M, Huang X, Fan N (2016) Altered serum levels of TNF-α, IL-6 and IL-18 in manic, depressive, mixed state of bipolar disorder patients. Psychiatry Res, 244:19-23.
  • Lynch ME (2001) Antidepressants as analgesics. A review of randomised controlled trials examining analgesic effects of antidepressant agents. J Psychiatry Neurosci, 26:30-36.
  • Manzo C, Gareri P, Castagna A (2017) Psychomotor agitation following treatment with hydroxychloroquine. drug Saf Case Rep, 4:6.
  • Marchand F, Perretti M, McMahon SB (2005) Role of the immune system in chronic pain. Nat Neurosci, 6:521-532.
  • Marrie RA, Walld R, Bolton JM, Sareen J, Walker JR, Patten SB et al. (2019) CIHR Team in defining the burden and managing the effects of psychiatric comorbidity in chronic ımmunoinflammatory disease. rising incidence of psychiatric disorders before diagnosis of immune-mediated inflammatory disease. Epidemiol Psychiatr Sci, 28:333-342.
  • Matcham F, Rayner L, Steer S, Hotopf M (2013) The prevalence of depression in rheumatoid arthritis: a systematic review and meta-analysis. Rheumatology, 52:2136-2148.
  • McGowan PO, Sasaki A, D’Alessio AC, Dymov S, Labonte B, Szyf M et al. (2009) Epigenetic regulation of the glucocorticoid receptor in human brain associates with childhood abuse. Nat Neurosci, 12:342-348.
  • Mehta D, Klengel T, Conneely KN, Smith AK, Altmann A, Pace TW et al. (2013) Childhood maltreatment is associated with distinct genomic and epigenetic profiles in posttraumatic stress disorder. Proc Natl Acad Sci U S A, 110:8302-8307.
  • Mei L, Nave KA (2014) Neuregulin-ERBB signaling in the nervous system and neuropsychiatric diseases. Neuron, 83:27–49.
  • Miller AH, Maletic V, Raison CL (2009) Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression. Biol Psychiatry, 65:732-741.
  • Miller AH, Raison CL (2016) The role of inflammation in depression: from evolutionary imperative to modern treatment target. Nat Rev Immunol, 16:22–34.
  • Miller BJ, Buckley P, Seabolt W, Mellor A, Kirkpatrick B (2011) Meta-analysis of cytokine alterations in schizophrenia: clinical status and antipsychotic effects. Biol Psychiatry, 70:663–671.
  • Modabbernia A, Taslimi S, Brietzke E, Ashrafi M (2013) Cytokine alterations in bipolar disorder: a meta-analysis of 30 studies. Biol Psychiatry, 74:15–25.
  • Mok C, Lok E, Cheung E (2012) Concurrent psychiatric disorders are associated with significantly poorer quality of life in patients with rheumatoid arthritis. Scand J Rheumatol, 41:253–259.
  • Munkholm K, Vinberg M, Vedel Kessing L (2013) Cytokines in bipolar disorder: a systematic review and meta-analysis. J Affect Disord, 144:16–27.
  • Najjar S, Pearlman DM, Alper K, Najjar A, Devinsky O (2013) Neuroinflammation and psychiatric illness. J Neuroinflammation, 10:43.
  • Nakajima A, Kamitsuji S, Saito A, Tanaka E, Nishimura K, Horikawa N et al. (2006) Disability and patient’s appraisal of general health contribute to depressed mood in rheumatoid arthritis in a large clinical study in Japan. Mod Rheumatol, 16:151-157.
  • Nikolaus S, Bode C, Taal E, de Laar MA (2013) Fatigue and factors related to fatigue in rheumatoid arthritis: a systematic review. Arthritis Care Res (Hoboken), 65:1128–1146.
  • Obal F, Krueger JM (2003) Biochemical regulation of non-rapid-eyemovement sleep. Front Biosci, 8:520.
  • Oliveira J, Busson M, Etain B, Jamain S, Hamdani N, Boukouaci W et al. (2014) Polymorphism of Toll-like receptor 4 gene in bipolar disorder. J Affect Disord, 152-154:395-402.
  • Opp MR (2005) Cytokines and sleep. Sleep Med Rev, 9:355–364. O’Shea JJ, Plenge R (2012) JAKs and STATs in immunoregulation and immune-mediated disease. Immunity, 4:542–550.
  • Öncü J, Başoğlu F, Kuran B (2013) A comparison of impact of fatigue on cognitive, physical, and psychosocial status in patients with fibromyalgia and rheumatoid arthritis. Rheumatol Int, 33:3031-3037.
  • Paaby AB, Rockman MV (2013) The many faces of pleiotropy. Trends Genet, 29:66-73.
  • Pace TW, Mletzko TC, Alagbe O, Musselman DL, Nemeroff CB, Miller AH et al. (2006) Increased stress-induced inflammatory responses in male patients with major depression and increased early life stress. Am J Psychiatry, 163:1630-1633.
  • Pace TW, Hu F, Miller AH (2007) Cytokine-effects on glucocorticoid receptor function: relevance to glucocorticoid resistance and the pathophysiology and treatment of major depression. Brain Behav Immun, 21:9-19.
  • Pace TW, Miller AH (2009) Cytokines and glucocorticoid receptor signaling. Relevance to major depression. Ann NY Acad Sci, 1179:86-105.
  • Pålsson E, Jakobsson J, Södersten K, Fujita Y, Sellgren C, Ekman CJ et al. (2015) Markers of glutamate signaling in cerebrospinal fluid and serum from patients with bipolar disorder and healthy controls. Eur Neuropsychopharmacol, 25:133-140.
  • Panés J, Su C, Bushmakin AG, Cappelleri JC, Mamolo C, Healey P (2015) Randomized trial of tofacitinib in active ulcerative colitis: analysis of efficacy based on patient-reported outcomes. BMC Gastroenterol, 5:15.
  • Panés J, Vermeire S, Lindsay JO, Sands BE, Su C, Friedman G et al. (2018) Tofacitinib in patients with ulcerative colitis: health-related quality of life in phase 3 randomised controlled induction and maintenance studies. J. Crohns Colitis, 2:145–156.
  • Perroud N, Paoloni-Giacobino A, Prada P, Olie E, Salzmann A, Nicastro R et al. (2011) Increased methylation of glucocorticoid receptor gene (NR3C1) in adults with a history of 49 childhood maltreatment: a link with the severity and type of trauma. Transl Psychiatry, 1:e59.
  • Persson LO, Larsson BM, Nived K, Eberhardt K (2005) The development of emotional distress in 158 patients with recently diagnosed rheumatoid arthritis: a prospective 5‐year follow‐up study. Scand J Rheumatol, 34:191–197.
  • Pervanidou P (2008) Biology of post-traumatic stress disorder in childhood and adolescence. J Neuroendocrinol, 20:632-638.
  • Pervanidou P, Chrousos GP (2012) Metabolic consequences of stress during childhood and adolescence. Metabolism, 61:611-619.
  • Pollard L, Choy E, Gonzalez J, Khoshaba B, Scott D (2006) Fatigue in rheumatoid arthritis reflects pain, not disease activity. Rheumatology (Oxford), 45:885–889.
  • Qiu XJ, Zhang XL, Cai LS, Yan C, Yu L, Fan J et al. (2019) Rheumatoid arthritis and risk of anxiety: a meta-analysis of cohort studies. Clin Rheumatol, 38:2053-2061.
  • Rao JS, Harry GJ, Rapoport SI, Kim HW (2010) Increased excitotoxicity and neuroinflammatory markers in postmortem frontal cortex from bipolar disorder patients. Mol Psychiatry, 15:384–392.
  • Rege S, Hodgkinson SJ (2013) Immune dysregulation and autoimmunity in bipolar disorder: synthesis of the evidence and its clinical application. Aust N Z J Psychiatry, 47:1136-1151.
  • Rosenblat JD, Kakar R, Berk M, Kessing LV, Vinberg M, Baune BT et al. (2016) Anti-inflammatory agents in the treatment of bipolar depression: a systematic review and meta-analysis. Bipolar Disord, 2:89–101.
  • Rosenblat JD, McIntyre RS (2015) Are medical comorbid conditions of bipolar disorder due to immune dysfunction? Acta Psychiatr Scand, 132:180–191.
  • Rosenblat JD, McIntyre RS (2017) Bipolar disorder and immune dysfunction: epidemiological findings, proposed pathophysiology and clinical implications. Brain Sci, 7:144.
  • Rupp I, Boshuizen HC, Jacobi CE, Dinant H J, van den Bos GA (2004) Impact of fatigue on health-related quality of life in rheumatoid arthritis. Arthritis Care Res (Hoboken), 51:578-585.
  • Saglam Aykut D, Arslan FC, Ozkorumak Karaguzel E, Aral G, Karakullukcu S (2018) The relationship between neutrophil-lymphocyte, plateletlymphocyte ratio and cognitive functions in bipolar disorder. Nord J Psychiatry, 72:119-23.
  • Sasayama D, Hattori K, Wakabayashi C, Teraishi T, Hori H et al. (2013) Increased cerebrospinal fluid interleukin-6 levels in patients with schizophrenia and those with major depressive disorder. J Psychiatr Res, 47:401-406.
  • SayuriYamagata A, Brietzke E, Rosenblat JD, Kakar R, McIntyre RS (2017) Medical comorbidity in bipolar disorder: The link with metabolicinflammatory systems. J Affect Disord, 11:99-106.
  • Schatzberg AF, Nemeroff CB (2009) Textbook of Psychopharmacology, 4th ed. Washington, American Psychiatric Publishing.
  • Schiff M, Takeuchi T, Fleischmann R, Gaich CL, DeLozier AM, Schlichting D et al. (2017) Patient-reported outcomes of baricitinib in patients with rheumatoid arthritis and no or limited prior disease-modifying antirheumatic drug treatment. Arthritis Res Ther, 19:208.
  • Scholz J, Broom DC, Youn DH, Mills CD, Kohno T, Suter MR (2005) Blocking caspase activity prevents transsynaptic neuronal apoptosis and the loss of inhibition in lamina II of the dorsal horn after peripheral nerve injury. J Neurosci, 25:7317-7323.
  • Scott DL, Wolfe F, Huizinga TWJ (2010) Rheumatoid arthritis. Lancet, 376:1094-1108.
  • Seif F, Khoshmirsafa M, Aazami H, Mohsenzadegan M, Sedighi G, Bahar M (2017) The role of JAK-STAT signaling pathway and its regulators in the fate of T helper cells. Cell Commun Signal, 15:23.
  • Singhal A, Ross J, Seminog O, Hawton K, Goldacre MJ (2014) Risk of selfharm and suicide in people with specific psychiatric and physical disorders: comparisons between disorders using English national record linkage. J R Soc Med, 107:194-204.
  • Söderlund J, Olsson SK, Samuelsson M, Walther-Jallow L, Johansson C et al. (2011) Elevation of cerebrospinal fluid interleukin-1ß in bipolar disorder. J Psychiatry Neurosci, 36:114–118.
  • Spiliotaki M, Salpeas V, Malitas P, Alevizos V, Moutsatsou P (2006) Altered glucocorticoid receptor signaling cascade in lymphocytes of bipolar disorder patients. Psychoneuroendocrinology, 31:748-760.
  • Straub RH, Cutolo M (2001) Involvement of the hypothalamic–pituitary– adrenal/gonadal axis and the peripheral nervous system in rheumatoid arthritis: viewpoint based on a systemic pathogenetic role. Arthritis Rheum, 44:493–507.
  • Straub RH (2014) Rheumatoid arthritis: stress in RA: a trigger of proinflammatory pathways? Nat Rev Rheumatol, 10:516–518.
  • Szekanecz Z, Vegvari A, Szabo Z, Koch AE (2010) Chemokines and chemokine receptors in arthritis. Front Biosci (Schol Ed) 2:153–167. Thomas KS, Motivala S, Olmstead R, Irwin MR (2011) Sleep depth and fatigue: role of cellular inflammatory activation. Brain Behav Immun, 25:53–58.
  • Thomsen AF, Kvist TK, Andersen PK, Kessing LV (2005) Increased risk of affective disorder following hospitalisation with hyperthyroidism - a register-based study. Eur J Endocrinol, 152:535-543.
  • Torrey EF, Yolken RH (2001) The schizophrenia-rheumatoid arthritis connection: infectious, immune, or both? Brain Behav Immun, 15:401–410. Traynor K (2012) FDA approves tofacitinib for rheumatoid arthritis. Am J Health Syst Pharm, 24:2120.
  • Trickett PK, Noll JG, Susman EJ, Shenk CE, Putnam FW (2010) Attenuation of cortisol across development for victims of sexual abuse. Dev Psychopathol, 22:165-175.
  • Tylee DS, Sun J, Hess JL et al. (2018) Genetic correlations among psychiatric and immune-related phenotypes based on genome-wide association data. Am J Med Genet B Neuropsychiatr Genet, 177:641-57.
  • Tyrka AR, Price LH, Marsit C, Walters OC, Carpenter LL (2012) Childhood adversity and epigenetic modulation of the leukocyte glucocorticoid receptor: preliminary findings in healthy adults. PLoS One, 7:e30148.
  • Uhlig T, Moe RH, Kvien TK (2014) The burden of disease in rheumatoid arthritis. Pharmacoeconomics, 32:841–851.
  • Van’t LH, Verdurmen J, Ten HM, van Dorsselaer S, Beekman A et al. (2010) The association between arthritis and psychiatric disorders; results from a longitudinal population-based study. J Psychosom Res, 68:187–193.
  • Vasilakos J, Shivers B (1996) Watch for ICE in neurodegeneration. Mol Psychiatry, 1:72-76.
  • Vieira MMM, Ferreira TB, Pacheco PAF, Barros PO, Almeida CRM, AraújoLima CF et al. (2010) Enhanced Th17 phenotype in individuals with generalized anxiety disorder. J Neuroimmunol, 229:212–218.
  • Wang Q, Yang C, Gelernter J, Zhao H (2015) Pervasive pleiotropy between psychiatric disorders and immune disorders revealed by integrative analysis of multiple GWAS. Hum Genet, 134:1195–1209.
  • Waraich P, Goldner EM, Somers JM, Hsu L (2004) Prevalence and incidence studies of mood disorders: a systematic review of the literature. Can J Psychiatry, 49:124–38.
  • Warrington TP, Bostwick JM (2006) Psychiatric adverse effects of corticosteroids. Mayo Clin Proc, 81:1361-1367.
  • Weaver IC, Cervoni N, Champagne FA, D’Alessio AC, Sharma S, Seckl JR et al. (2004) Epigenetic programming by maternal behavior. Nat Neurosci, 7:847-54.
  • Wolfe F, Michaud K (2009) Predicting depression in rheumatoid arthritis: the signal importance of pain extent and fatigue, and comorbidity. Arthritis Care Res (Hoboken), 61:667–673.
  • Woolf CJ, Costigan M (1999) Transcriptional and posttranslational plasticity and the generation of inflammatory pain. Proc Natl Acad Sci U S A, 96:7723-7730.
  • Woolf CJ, Salter MW (2000) Neuronal plasticity: increasing the gain in pain. Science, 288:1765-1769.
  • Yaron I, Shirazi I, Judovich R, Levartovsky D, Caspi D, Yaron M (1999) Fluoxetine and amitriptyline inhibit nitric oxide, prostaglandin E2, and hyaluronic acid production in human synovial cells and synovial tissue cultures. Arthritis Rheum, 42:2561-2568.
  • Zetterberg H, Jakobsson J, Redsäter M, Andreasson U, Pålsson E, Ekman CJ et al. (2014) Blood-cerebrospinal fluid barrier dysfunction in patients with bipolar disorder in relation to antipsychotic treatment. Psychiatry Res, 217:143-146.
  • Zunszain PA, Anacker C, Cattaneo A, Carvalho LA, Pariante CM (2011) Glucocorticoids, cytokines and brain abnormalities in depression. Prog Neuropsychopharmacol Biol Psychiatry, 35:722-729.
APA Kara M, Sarandöl A, AKKAYA C (2022). Bipolar Bozukluk ve Romatoid Artrit İlişkisi. , 131 - 142. 10.18863/pgy.921569
Chicago Kara Melike,Sarandöl Aslı,AKKAYA Cengiz Bipolar Bozukluk ve Romatoid Artrit İlişkisi. (2022): 131 - 142. 10.18863/pgy.921569
MLA Kara Melike,Sarandöl Aslı,AKKAYA Cengiz Bipolar Bozukluk ve Romatoid Artrit İlişkisi. , 2022, ss.131 - 142. 10.18863/pgy.921569
AMA Kara M,Sarandöl A,AKKAYA C Bipolar Bozukluk ve Romatoid Artrit İlişkisi. . 2022; 131 - 142. 10.18863/pgy.921569
Vancouver Kara M,Sarandöl A,AKKAYA C Bipolar Bozukluk ve Romatoid Artrit İlişkisi. . 2022; 131 - 142. 10.18863/pgy.921569
IEEE Kara M,Sarandöl A,AKKAYA C "Bipolar Bozukluk ve Romatoid Artrit İlişkisi." , ss.131 - 142, 2022. 10.18863/pgy.921569
ISNAD Kara, Melike vd. "Bipolar Bozukluk ve Romatoid Artrit İlişkisi". (2022), 131-142. https://doi.org/10.18863/pgy.921569
APA Kara M, Sarandöl A, AKKAYA C (2022). Bipolar Bozukluk ve Romatoid Artrit İlişkisi. Psikiyatride Güncel Yaklaşımlar, 14(2), 131 - 142. 10.18863/pgy.921569
Chicago Kara Melike,Sarandöl Aslı,AKKAYA Cengiz Bipolar Bozukluk ve Romatoid Artrit İlişkisi. Psikiyatride Güncel Yaklaşımlar 14, no.2 (2022): 131 - 142. 10.18863/pgy.921569
MLA Kara Melike,Sarandöl Aslı,AKKAYA Cengiz Bipolar Bozukluk ve Romatoid Artrit İlişkisi. Psikiyatride Güncel Yaklaşımlar, vol.14, no.2, 2022, ss.131 - 142. 10.18863/pgy.921569
AMA Kara M,Sarandöl A,AKKAYA C Bipolar Bozukluk ve Romatoid Artrit İlişkisi. Psikiyatride Güncel Yaklaşımlar. 2022; 14(2): 131 - 142. 10.18863/pgy.921569
Vancouver Kara M,Sarandöl A,AKKAYA C Bipolar Bozukluk ve Romatoid Artrit İlişkisi. Psikiyatride Güncel Yaklaşımlar. 2022; 14(2): 131 - 142. 10.18863/pgy.921569
IEEE Kara M,Sarandöl A,AKKAYA C "Bipolar Bozukluk ve Romatoid Artrit İlişkisi." Psikiyatride Güncel Yaklaşımlar, 14, ss.131 - 142, 2022. 10.18863/pgy.921569
ISNAD Kara, Melike vd. "Bipolar Bozukluk ve Romatoid Artrit İlişkisi". Psikiyatride Güncel Yaklaşımlar 14/2 (2022), 131-142. https://doi.org/10.18863/pgy.921569
Sayfa Oluşturulma Tarihi
29-04-2024 11:21

İLETİŞİM

TÜBİTAK ULAKBİM TR Dizin

Yüzüncüyıl, İşçi Blokları Mahallesi

Muhsin Yazıcıoğlu Caddesi No:51/C

06530 Çankaya / ANKARA +90 (312) 298 92 00

trdizin@tubitak.gov.tr

TÜBİTAK ULAKBİM Ulusal Akademik Ağ ve Bilgi Merkezi Cahit Arf Bilgi Merkezi © Tüm Hakları Saklıdır. Gizlilik Politikası Kullanım Şartları